CN Patent

CN103130787B — 嘧啶酮酰胺类化合物及其制备方法、抗hiv活性和抗tmv活性

Assigned to Nankai University · Expires 2015-06-10 · 11y expired

What this patent protects

本发明涉及嘧啶酮酰胺类化合物I以及它们的制备、抗HIV活性和抗TMV活性。通式I具有很好的抗艾滋病病毒活性和抗烟草花叶病毒活性，能很好地抑制艾滋病病毒(HIV)和烟草花叶病毒(TMV)。 式中取代基R 1 和R 2 具体所指代的内容见说明书。

USPTO Abstract

本发明涉及嘧啶酮酰胺类化合物I以及它们的制备、抗HIV活性和抗TMV活性。通式I具有很好的抗艾滋病病毒活性和抗烟草花叶病毒活性，能很好地抑制艾滋病病毒(HIV)和烟草花叶病毒(TMV)。 式中取代基R 1 和R 2 具体所指代的内容见说明书。

Drugs covered by this patent

Patent Metadata

Patent number
CN103130787B
Jurisdiction
CN
Classification
—
Expires
2015-06-10
Drug substance claim
No
Drug product claim
No
Assignee
Nankai University
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.